400,0
+0,00%
2026-10-16
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +114.4% | +130.4% | 3 / 3 | +22.6% | +3.98 pp | +80.05 pp | -0.2% | -0.29 | 1.11 | 5,5 | +22,6% | 0,2 | +106,1% | 1.11 | -0.14 | — |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 400,0 (close price on 2026-10-16)EPS (TTM): 360,0
Financial charts
1.Revenue & growth
VND bn5,54Q2/26
1.Revenue & growth
VND bn5,54Q2/26
2.Profit & growth
VND bn0,21Q2/26
3.Profit mix (Penman)
VND bn3,12Q2/26
4.Margins & cost structure
%24.0%Q2/26
5.Returns & cash cycle
% · days
Outlier warning: 19 period(s) outside -1.825…1.825 days, drawn at the limit
6.Earnings quality & cash
VND bn1,18Q2/26
7.Asset structure
VND bn11,8Q2/26
8.Funding & debt health
VND bn · times11,8Q2/26
9.Revenue backlog
VND bn0,49Q2/26
10.Valuation
times · %1,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %10Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26